Epinastine
Alternative Names: Alesion Tablet; Flurinol; Talerc; WAL 801; WAL 801 CLLatest Information Update: 25 Sep 2021
At a glance
- Originator Boehringer Ingelheim
- Class Antiallergics; Dibenzazepines; Eye disorder therapies; Imidazoles; Nonsedating antihistamines; Small molecules
- Mechanism of Action Histamine H1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Allergic rhinitis; Asthma; Atopic dermatitis; Dermatitis; Psoriasis; Urticaria
Most Recent Events
- 01 Aug 2005 Sankyo has terminated its licence for Epinastine in Japan
- 23 Mar 2005 Alesion Dry Syrup has been launched in Japan for the treatment of allergic rhinitis, urticaria and pruritus
- 27 Jan 2005 Alesion® Dry Syrup has received manufacturing approval in Japan